Stago

Stago, founded in 1945, started from pharmaceutical analysis and has now become a leader in the field of thrombosis and hemostasis diagnostics within the in vitro diagnostics (IVD) industry.As an independent multinational trading company, Stago is fully committed to the exploration of thrombosis and hemostasis. Stago continuously enhances the quality of services in healthcare by providing advanced laboratory testing systems, excellent technical services, and professional supporting products (reagents, instruments, and consumables). At the same time, Stago's subsidiaries and distributor network are spread across more than 110 countries and regions worldwide, ensuring that customers receive high-quality services and products to meet the needs of global healthcare systems.Today, over 90% of Stago’s products are still researched, developed, produced, and exported from its home base in France. With over 60 years of expertise in the field of thrombosis and hemostasis, Stago has accumulated solid industry experience (in R&D, standardization, and product development) and gained long-term recognition from professionals in related scientific fields. With the advancement of the biomedical field, more discoveries require the use of new diagnostic markers and more precise diagnostic tools, which also drives the continuous progression of medicine towards personalized healthcare.